Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in: Journal of Diabetes & Metabolic Disorders 1/2014

Open Access 01-12-2014 | Research article

The effect of opium addiction on thyroid function tests

Authors: Mohammad Hossein Gozashti, Elham Mohammadzadeh, Kouros Divsalar, Mostafa Shokoohi

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2014

Login to get access

Abstract

Background

A number of abnormalities has been identified among drug addicted users especially heroin addicts. However, there are a few studies to assess the opium effects on thyroid hormones. the aim of the present study is to investigate the effect of opium on the thyroid function tests.

Method

In this case–control, 50 male addicts, aged 20–50 years, with history of addiction to opium lasting more than two years, and 50 male non-addicts as control group were randomly selected. 10 cc blood sample was taken for measurements of TSH, total T4 and T3, free T4 and T3, and T3 resin uptake (T3RU) and 50 cc urine sample for opium testing.

Results

The univariate analysis revealed that there was not a significant association between opium and serum levels of T4 and TSH, but compared with control group, a slight increase in total T3 and a decrease in T3RU were observed among addicts (P < 0.05). In multivariate analysis, opium was also found to exert a lowering effect on serum free T4 level after adjusting of age and cigarette smoking (P < 0.05).

Conclusion

The findings of the present study demonstrated that opium can influence on thyroid function by increasing total T3 and decreasing T3RU and free T4 levels.
Literature
1.
Singer M: Drugs and development: The global impact of drug use and trafficking on social and economic development. Int J Drug policy 2008, 19: 467–478. 10.1016/j.drugpo.2006.12.007CrossRefPubMed
2.
Ahmadi J, Pridmore S, Alimi A, Cheraghi A, Arad A, Parsaeyan H, et al.: Epidemiology of opium use in the general population. Am J Drug Alcohol Abuse 2007, 33(3):483–491. 10.1080/00952990701301293CrossRefPubMed
3.
Najafi M, Sheikhvatan M, Ataie-Jafari A: Effects of opium use among coronary artery disease patients in Iran. Subst Use Misuse 2010, 45(14):2579–2581. 10.3109/10826081003793904CrossRefPubMed
4.
Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F: Effect of opium addiction on diabetes. Am J Drug Alcohol Abuse 2008, 34(4):383–388. 10.1080/00952990802122580CrossRefPubMed
5.
Gharagozlou H, Behin MT: Frequency of psychiatric symptoms among 150 opium addicts in Shiraz, Iran. Subst Use Misuse 1979, 14(8):1145–1149. 10.3109/10826087909048703
6.
Rangi G, De-lauretis L, Bestetti O, Sghedoni D, Gambaro V, et al.: Gonadal Function in male heroin and methadone addicts. Int J Androl 1998, 11(2):93–100.
7.
Hermann D, Heinz A, Mann K: Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholism. Addiction 2002, 97(11):1369–1381. 10.1046/j.1360-0443.2002.00200.xCrossRefPubMed
8.
Brambilla F, Nobile P, Zanoboni A, Zanoboni-Musiaccia W, Meroni PL: Effects of chronic heroin addiction on pituitary-thyroid function in man. J Endocrinol Invest 1980, 3(3):251–255.CrossRefPubMed
9.
Rasheed A, Tareen IA: Effects of heroin on thyroid function, cortisol and testosterone level in addicts. Pol J Pharmacol 1995, 47(5):441–444.PubMed
10.
Bhargava HN, Das S, Bansinath M, Prasad R: The binding of 3H-(3-Mehis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats. Pharmacol Biochem Behav 1989, 34(1):7–12. 10.1016/0091-3057(89)90344-4CrossRefPubMed
11.
Benavides M, Laorden ML, Garcia-Borron JC, Milanes MV: Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioids withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN. Eur J Neurosci 2003, 17(1):103–112. 10.1046/j.1460-9568.2003.02434.xCrossRefPubMed
12.
Gabriel SM, Simpkins JW, Millard WJ: Changes in anterior pituitary hormone secretion and hypothalamic catecholamine metabolism during morphine withdrawal in the female rat. Brain Res 1985, 346(1):15–21. 10.1016/0006-8993(85)91089-3CrossRefPubMed
13.
Pfeiffer DG, Pefeiffer A: Opiate suppression of LH secretion involves central receptors different from those that mediating opiate effects on prolactin secretion. J Endocrinol 1987, 114: 469–476. 10.1677/joe.0.1140469CrossRefPubMed
14.
Saboory E, Derchasky M, Ismaili M, Jahromi SS, Brull R, Carlen PL, El Beheiry H: Mechanisems of morphine enhancement of spontaneous seizure activity. Anesth Analg 2007, 105(6):1729–1735. 10.1213/01.ane.0000287675.15225.0bCrossRefPubMed
15.
Cicero TJ, Schainker BA, Meyer ER: Endogenus opioids participate in the regulation of the hypothalamicpituitary- luteinizing hormone axis and testosterone negative feedback control of luteinizing hormone. Endocrinology 1979, 104: 1286–1291. 10.1210/endo-104-5-1286CrossRefPubMed
16.
Buchbaur G, Nikiforov A, Rembarg B: Head space constituents of opium. Planta Med 1994, 60: 181–183. 10.1055/s-2006-959447CrossRef
17.
Bossone CA, Hannon JP: Metabolic actions of morphine in conscious chronically instrumental pigs. Am J physical 1991, 260: 1051–1057.
18.
Ipp E, Dobbs R, Unger RH: Morphine and beta-endorphin in fluence the secretion of the endocrine pancreas. Nature 1978, 276: 190–191. 10.1038/276190a0CrossRefPubMed
19.
Ipp E, Schusdziarra V, Harris V, Unger RH: Morphine induced hyperglycemia:role of insulin and glucagon. Endocrinology 1980, 107: 461–463. 10.1210/endo-107-2-461CrossRefPubMed
20.
del Valle-Soto ME, Iglesias L, Calzada B, Vega JA, Hernandez LC, Perez-Casas A: Effects of morphine on the pituitary-thyroid axis: morphological and analytical studies. Funct Dev Morphol 1991, 1(4):3–6.PubMed
21.
Idanpaan-Heikkila JJ, Rauhala P, Tuominen RK, Tuomainen P, Zolotov N, Mannisto PT: Morphine withdrawal alters anterior pituitary hormone secretion, brain endopeptidase activity and brain monoamine metabolism in the rat. Pharmacol Toxicol 1996, 78(3):129–135. 10.1111/j.1600-0773.1996.tb00193.xCrossRefPubMed
22.
Hochberg Z, Pacak K, Chrousos GP: Endocrine withdrawal syndromes. Endocr Rev 2003, 24(4):523–538. 10.1210/er.2001-0014CrossRefPubMed
23.
Rauhala P, Mannisto PT, Tuominen RK: Effects of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat. J Pharmacol Exp Ther 1988, 246(2):649–654.PubMed
24.
Dogar IA, Ali MS, Rehman S: Addictive drugs’ effect on haematological and hormonal profiles in men. Professional Med J 2005, 12(3):237–246.
25.
Shahsavar F, Ghanadi K, Jafarzadeh M, Nasiri B, Forutani S: Opium addiction decreases T3 uptake amount. Life Science Journal 2013, 10(5s):485–487.
26.
Zhang GF, Tang YL, Smith AK, Liu ZQ, Sheng LX, Chi Y, et al.: Alterations in pituitary-thyroid axis function among opioid-dependent subjects after acute and protracted abstinence. Addict Biol 2009, 14(3):310–4. 10.1111/j.1369-1600.2008.00144.xCrossRefPubMed
27.
Bhoir KK, Suryawanshi SA, Pandey AK: Effects of sub-lethal heroin administration on thyroid stimulating hormone (TSH), thyroid hormones (T3, T4) and thyroid gland of Mus norvegicus. J Environ Biol 2009, 30(6):989–94.PubMed
28.
Yan Z, Yan H, Ou H: Human thyroxine binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern. Gene 2012, 506(2):289–94. 10.1016/j.gene.2012.07.009CrossRefPubMed
29.
Afrasiabi MA, Flomm M, Friedlander H, Valenta LJ: Endocrine studies in heroin addicts. Psychoneuroendocrinology 1978, 4: 145–153.CrossRef
30.
Azizi F, Vagenakis AG, Portnay GI, et al.: Thyroxine transport and metabolism in methadone and heroin addicts. Ann Intern Med 1974, 80: 194–9. 10.7326/0003-4819-80-2-194CrossRefPubMed
31.
George S: Review of neuroendocrine correlates of chronic opiate misuse: dysfunctions and pathophysiological mechanisms. Addict Disord Treat 2005, 4(3):99–109. 10.1097/01.adt.0000161633.63378.fbCrossRef
32.
Pende A, Musso NR, Montaldi ML, Pastorino G, Arzese M, Devilla L: Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men. Biomed Pharmacother 1986, 40(5):178–182.PubMed
33.
Chan V, Wang C, Yeung RT: Effects of heroin addiction on thyrotrophin, thyroid hormones and porlactin secretion in men. Clin Endocrinol 1979, 10(6):557–565. 10.1111/j.1365-2265.1979.tb02115.xCrossRef
34.
Shenkman L, Massie B, Mitsuma T, Hollander CS: Effects of chronic methadone administration on the hypothalamic–pituitary–thyroid axis. J Clin Endocrinol Metab 1972, 35(1):169–170. 10.1210/jcem-35-1-169CrossRefPubMed
Metadata
Title
The effect of opium addiction on thyroid function tests
Authors
Mohammad Hossein Gozashti
Elham Mohammadzadeh
Kouros Divsalar
Mostafa Shokoohi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2014
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/2251-6581-13-5

Other articles of this Issue 1/2014

Journal of Diabetes & Metabolic Disorders 1/2014 Go to the issue

Research article

Activities of three erythrocyte enzymes of hyperglycemic rats (Rattus norvegicus) treated with Allium sativa extract

Research article

Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria

Research article

Effects of extremely low frequency electromagnetic fields on paraoxonase serum activity and lipid peroxidation metabolites in rat

Research article

Suboptimal glycaemic and blood pressure control and screening for diabetic complications in adult ambulatory diabetic patients in Uganda: a retrospective study from a developing country

Research article

A prospective single arm study of the effect of an acute oral glucose loading on the endothelial function of healthy participants

Research article

Serum HDL-C level of Iranian adults: results from sixth national Surveillance of Risk Factors of Non-Communicable Disease
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits